Clinical Trials: Breast Cancer

Alabama

Birmingham; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Birmingham; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Decatur; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Huntsville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Mobile; Southern Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Mobile; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Muscle Shoals; Northwest Alabama Cancer Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Alaska

Anchorage; Providence Cancer Center (Katmai Oncology Group)
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Anchorage; Alaska Cancer Research and Education Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Arizona

Phoenix; Precision Trials, LLC
Breast Scan

Scottsdale; Scottsdale Medical Specialists
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Scottsdale; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Tucson; Arizona Hematology Oncology
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Tucson ; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Arkansas

Fayetteville; Highlands Oncology Group
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Fayetteville; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Fayetteville; Highlands Oncology Group
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Hot Springs; Genesis Cancer Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Jonesboro; Northeast Arkansas Clinic
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Jonesboro; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Little Rock; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Little Rock; Little Rock Hematology Oncology Associates
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Little Rock; Research Site:
A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer

Various Cities; Research Center
HER2-positive Breast Cancer Study CRAD001J2101

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

California

Alhambra; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Anaheim; Pacific Cancer Medical Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Anaheim; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Anaheim; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bakersfield; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Bakersfield; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bakersfield; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Bakersfield; Comprehensive Blood and Cancer Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Baldwin Park; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Baldwin Park; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Bellflower; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bellflower; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Beverly Hills; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Burbank; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Campbell; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Chula Vista; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Concord; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Concord; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Concord; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Concord; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Corona; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Duarte; City of Hope
ECOG: E1Y97: Mapping Interactive Cancer Susceptibility Loci

Duarte; City of Hope
Biomarkers, Breast Density, and Risk Reduction Perspectives in BRCA Carriers

Duarte; City of Hope
Phase I-II Trial of ZD1839 (IRESSA), Trastuzumab (Herceptin), and Docetaxel (Taxotere) in Patients with erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma

Duarte; City of Hope
A Translational Breast Cancer Prevention Trial of Mushroom Powder in Postmenopausal Breast Cancer Survivors

Duarte; City of Hope
Sister Survivor: African American Breast Cancer Coalition

Duarte; City of Hope
SWOG S0500: A Randomized Phase III Trial to Test the Strategy of Changing Therapy versus Maintaining Therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at First Follow-Up Assessment

Duarte; City of Hope
The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients with Breast Cancer

Duarte; City of Hope
Age-Related Changes in Nanoparticle Albumin Bound (nab) Paclitaxel Pharmacokinetics and Pharmacodynamics

Duarte; City of Hope
NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (A1) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer

Duarte; City of Hope
NCIC CTG MAP.3 A Phase III Randomized Study of Exemestane vs Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer

Duarte; City of Hope
SWOG S0221: Phase III Trial of Continuous Schedule AC + G Vs. Every 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node Negative Breast Cancer

Duarte; City of Hope
NSABP Protocol B-39/RTOG 0413: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

Duarte; City of Hope
SWOG S0226: Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women with Metastatic Breast Cancer

Duarte; City of Hope
Phase II Study of Tandem Cycle Dose-Intense Chemotherapy of Mephalan and Carboplatin, Thiotepa, and Cyclophosphamide (STAMP V)+/-Trastuzumab followed by Helical Tomotherapy or Local Regional Radiation Therapy for Stage IV Metastatic and Stage IIIB/C Breast Cancer

Duarte; City of Hope
Randomized Phase II Study of Docetaxel, Adriamycin, and Cytoxan (TAC) Versus Adriamycin/Cytoxan, Followed By Abraxane/Carboplatin (ACAC) +/- Trastuzumab As Neoadjuvant Therapy for Patients with Stage I-III Breast Cancer

Duarte; City of Hope
Reducing the Burden of Breast Cancer Among African American and Latina Survivors

Duarte; City of Hope
Blood Tumor Markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up

Duarte; City of Hope
The Impact of Functional Strain on Psychological and Familial Functioning and Access to Follow-up Care Among Asian American Breast Cancer Survivors

Duarte; City of Hope
Multicenter Evaluation of Breast Cancer Patients and Outcomes of Care within the National Comprehensive Cancer Network (NCCN)

Duarte; City of Hope
CA180004: A Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Advanced Breast Cancer

Fontana; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fontana; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Fountain Valley; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Fountain Valley; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fountain Valley; Pacific Coast Hematology/Oncology Medical Group Inc
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Fountain Valley; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Fountain Valley; Pacific Coast Hematology/Oncology Medical Group, Inc.
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Fresno; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Fullerton; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fullerton; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Glendale; Glendale Memorial Hospital & Health Center, Hematology/Oncology Department
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Glendora; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Greenbrae; California Cancer Care Inc
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Greenbrae; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Greenbrae; California Cancer Care
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Hawthorne; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Hayward; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Hayward; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Huntington Beach; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Irvine; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Irvine; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

La Jolla; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

La Mesa; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

La Verne; Wilshire Oncology Medical Group, Inc.
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Lancaster; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Little Rock; California Oncology of the Central Valley
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Long Beach; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Long Beach; Breastlink Medical Group Inc
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Long Beach; Breastlink Medical Group Inc
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Long Beach; Breastlink Medical Group Inc
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Los Alamitos; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Los Angeles; UCLA
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy

Los Angeles; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Los Angeles; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Los Angeles; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Los Angeles; East Valley Hematology And Oncology Medical Group, Inc.
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Los Angeles; UCLA
A Study of Dasatinib (BMS-354825) in Patients With Advanced ‘Triple-Negative’ Breast Cancer

Los Angeles; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Los Angeles; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Los Angeles; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer

Mission Hills; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Modesto; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Montebello; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Monterey Park; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Northridge; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Oakland; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Oakland; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Oceanside; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Oxnard; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Oxnard; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Palm Springs; Comprehensive Cancer Center
A Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptor Negative

Palm Springs; Comprehensive Cancer Center
A Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptor Negative

Palm Springs; Comprehensive Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Palm Springs; Comprehensive Cancer Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Palm Springs; Palm Springs Desert Regional Medical Center - Comprehensive Cancer Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Palm Springs; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Panorama City; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Panorama City; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Pasadena; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Pleasant Hill; Bay Area cancer Research Group, LLC
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Pomona; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Pomona; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Rancho Cucamonga; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Rancho Mirage; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Rancho Mirage; Desert Hematology Oncology Medical Group Inc
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Redondo Beach; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Riverside; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Riverside; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Roseville; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Roseville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Sacramento; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Sacramento; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Sacramento; Sutter Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Sacramento; Sutter Cancer Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Sacramento; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

San Diego; University of California San Diego Medical Center
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy

San Diego ; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

San Diego ; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

San Diego ; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer

San Diego ; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

San Diego ; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

San Francisco; California Pacific Medical Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

San Francisco; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

San Francisco; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

San Francisco; UCSF Comprhensive Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

San Francisco; Ucsf-Comprehensive Cancer Center
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

San Francisco; Ucsf-Comprehensive Cancer Center
A Study of Dasatinib (BMS-354825) in Patients With Advanced ‘Triple-Negative’ Breast Cancer

San Francisco; Ucsf-Comprehensive Cancer Center
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer

San Jose; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

San Jose; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Santa Barbara; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Santa Barbara; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Santa Clara; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Santa Clara; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Santa Maria; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Santa Monica; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Solvang; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Soquel; Cancer Research and Prevention Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

South San Francisco ; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

South San Francisco ; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

St Helena; Gregory B. Smith MD
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Stanford; Stanford University School of Medicine
Study of self-conscious emotions in women living with breast cancer

Stanford; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Stanford; Stanford University School of Medicine
Stress and Breast Cancer Study

Sylmar; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Valencia; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Vallejo; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Vallejo; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Vallejo; Research Site:
A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer

Various Cities; Research Center
HER2-positive Breast Cancer Study CRAD001J2101

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Various Cities; Research Site
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Various Cities; Research Center
HER2-positive Metastatic Breast Cancer Study CLBH589C2204

Vista; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Walnut Creek; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Walnut Creek; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

West Covina; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Woodland Hills; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Woodland Hills; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Colorado

Aurora; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Aurora; University of Colorado Hospital - Anschutz Cancer Pavilion
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Aurora; University Of Colorado Cancer Center
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer

Colorado Springs; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Denver; Rocky Mountain Cancer Centers-Rose
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Denver; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Englewood; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fort Collins; Front Range Cancer Specialists
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Ft Collins; Front Range Cancer Specialists
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Grand Junction; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lafayette; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lone Tree; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Longmont; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Loveland; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Pueblo; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Thornton; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Wheat Ridge; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Connecticut

Bridgeport; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fairfield; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Fairfield; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Farmington; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Farmington; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Hartford; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Meriden; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Middlebury; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Middlebury; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Middletown; Connecticut Oncology Group
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Norwich; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Norwich; Eastern Connecticut Hematology & Oncology Associates
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Stamford; Hematology Oncology PC-Bennett Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Stamford; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Trumbull; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Trumbull; Oncology Associates of Bridgeport
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Trumbull; Oncology Associates of Bridgeport
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Trumbull; Oncology Associates of Bridgeport, P.C.
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Waterbury; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Florida

Aventura; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Aventura; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Aventura; South Florida Medical Research
Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease

Boca Raton; Boca Raton Community Hospital Inc
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Boca Raton; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Boca Raton; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Bonita Springs; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bonita Springs; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Bonita Springs; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Boynton Beach; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Boynton Beach; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Boynton Beach; Palm Beach Institute of Hematology and Oncology
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Bradenton; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bradenton; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Bradenton; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Brooksville; Pasco Hernando Oncology Associates, Inc
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Brooksville; Pasco Hernando Oncology Associates PA
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Cape Coral; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Cape Coral; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Cape Coral; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Coral Spring; Northwest Oncology & Hematology Associates
A Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptor Negative

Coral Springs; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Coral Springs; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Davie; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Davie; Florida Cancer Research Institute
A Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptor Negative

Daytona Beach; Halifax Medical Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Englewood; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Englewood; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fort Lauderdale; Holy Cross Hospital, Michael & Dianne Bienes Cancer Center
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Fort Myers; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Fort Myers; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fort Myers; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Gainesville; Gainesville Hematology/ Oncology Associates
A Phase II Study of Abraxane and Nexavar in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer

Gainesville; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Gainesville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Gainesville; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Gainesville; Gainesville Hematology Oncology Associates
A Phase II study of Abraxane and Nexavar in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer

Hollywood; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Hudson; Florida Cancer Institute
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Jacksonville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Jacksonville; Mayo Clinic Jacksonville
A Study of Dasatinib (BMS-354825) in Patients With Advanced ‘Triple-Negative’ Breast Cancer

Jacksonville; Mayo Clinic Jacksonville
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer

Jacksonville Beach; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lake Worth; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lake Worth; Medical Specialists of the Palm Beaches, Inc.
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Lake Worth; Hematology Oncology Associates
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Lakeland; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lakeland; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Melbourne; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Miami; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Miami; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Miami; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Miami; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer

Naples; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Naples; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Naples; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

New Port Richey; Pasco Hernando Oncology Associates PA
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

New Port Richey; Pasco Hernando Oncology Associates PA
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Orange Park; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Orlando; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Orlando; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Orlando; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Orlando; Florida Hospital Cancer Institute
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Orlando; Florida Hospital Cancer Institute
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Orlando; M.D. Anderson Cancer Center Orlando
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Palatka; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Palm Beach Gardens; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Plantation; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Plantation; Research Site:
A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer

Port Charlotte; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Port Charlotte; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Port Charlotte; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Port St Lucie; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Port St. Lucie; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Sarasota ; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Sarasota ; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Sarasota ; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

St. Augustine; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

St. Petersburg; Gulfcoast Oncology Associates
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Tamarac; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Tamarac; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Tampa; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Various Cities; Research Site
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Venice; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Venice; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Venice; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

West Palm Beach; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

West Palm Beach; Palm Beach Cancer Institute
The purpose of this study is to determine whether RTA 744 is effective in the treatment of breast cancer that has metastasized to the brain.

Winter Park; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Georgia

Albany; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Altanta; Peachtree Hematology & Oncology Associates
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Athens; Northeast Georgia Cancer Care
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Athens; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Atlanta; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Atlanta; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Atlanta; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Atlanta; Emory University
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Augusta; Augusta Oncology Associates
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Augusta; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Augusta; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Augusta; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Austell; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Carrolton; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Cartersville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Decatur; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Douglasville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Duluth; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Gainesville; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Lawrenceville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lawrenceville; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Macon; Central Georgia Cancer Care
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Macon ; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Marietta; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Marietta; NW Georgia Oncology Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Marietta; Northwest Georgia Onc Ctrs PC
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Marietta; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Marietta; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Marietta; Northwest Georgia Oncology Centers, PC
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Savannah; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Savannah; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Savannah; Memorial Health University Medical Center
ACOSOG Z1031: A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Drugs in Postmenopausal Women with Clinical Stage II/III Breast Cancer

Snellville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Stockbridge; Center of Hope for Cancers and Blood Disorders
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Tucker; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Tucker; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Tucker; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer

Valdosta; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Center
HER2-positive Breast Cancer Study CRAD001J2101

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Hawaii

Honolulu; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Idaho

Boise; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Boise; Mtn States Tumor Institute
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Coeur D'Alene; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Fruitland; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Meridian; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Nampa; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Twin Falls; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Illinois

Chicago; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Chicago; Hematology Oncology Associates of Illinois
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Chicago; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Chicago; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer

Chicago,; Robert H Lurie Comprehensive Cancer Center at Northwestern University
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Decatur; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Decatur; Cancer Care Specialists of Central Illinois
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Elgin; Sherman Health Systems
NSABP B-36 A clinical trial of adjuvant therapy comparing six cycles of 5-FU (5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) to four cycles of Adriamycin and Cyclophosphamide (AC) with or without Celecoxib, in patients with node-negative breast cancer.

Elgin; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Elgin; Sherman Health Systems
SWOG S0226 "Phase III randomized trial of anastrozole versus anastrozole and fluvestrant as first line therapy for post menopausal women with metastatic breast cancer" Eligible patients will be randomized into one of two study groups: Arm 1 Anastrozole crossover to fulvestrant Arm 2 Anastrozole and fulvestrant

Elgin; Sherman Health Systems
(URCC U1105) Prevention of delayed nausea-- a phase III double-blind placebo-controlled clinical trial for breast cancer patients who are chemotherapy naïve

Elk Grove Village; Alexian Brothers Cancer Institute
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Galesburg; Medical & Surgical Specialists
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Harvey; Ingalls Memorial Hospital (Monroe Medical)
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Joliet; Midwest Center for Hematology Oncology
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Maywood; Loyola University Medical Center
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer

Maywood; Loyola University Medical Center
A Study of Dasatinib (BMS-354825) in Patients With Advanced ‘Triple-Negative’ Breast Cancer

Napersville; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Naperville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Park Ridge; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Peoria; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Plainfield; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Quincy; Quincy Medical Group
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Quincy; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Skokie; Edward H Kaplan MD & Assoc dba: Hematology/Oncology of the North Shore
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Urbana; Carle Cancer Research
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Various Cities; Research Site
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Yorkville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Zion; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Indiana

Bedford; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Beech Grove; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Bloomington; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Ft. Wayne; Fort Wayne Medical Oncology and Hematology, Inc.
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Indianapolis; Hematology Oncology of Indiana
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Indianapolis ; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Indianapolis ; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Indianapolis ; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Munster; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

New Albany; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

New Albany; Cancer Care Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

South Bend; Northern Indiana Cancer Research Consortium
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Terre Haute; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Vincennes; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Vincennes; Family Medicine of Vincennes Clinical Trial Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Iowa

Iowa City; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Iowa City; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Iowa City; University Of Iowa Hospitals And Clinics
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Iowa City; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Waterloo; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Kansas

Lawrence; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Overland Park; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Westwood; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Wichita; Cancer Center of Kansas
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Wichita; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Kentucky

Crestview Hills; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lexington; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Louisville; Kentuckiana Cancer Institute PLLC
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Louisville; James Graham Brown Cancer Center
A Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptor Negative

Louisville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Louisville; Kentuckiana Cancer Institute
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Louisville; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Louisville; Kentuckiana Cancer Institute PLLC
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Louisiana

Baton Rouge; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Baton Rouge; Mary Bird Perkins Cancer Center
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Baton Rouge; Mary Bird Perkins Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Lafayette; Acadiana Medical Oncology
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Lafayette; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Metairie; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

New Orleans; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Shreveport; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Maine

Bangor; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Scarborough; Maine Center for Cancer Medicine & Blood Disorders
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Scarborough; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Scarborough; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Scarborough; Research Site:
A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer

Scarborough; Research Site:
A Study of Epothilone D in Patients With Metastatic Breast Cancer

Scarbrough; Maine Center for Cancer Medicine
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Maryland

Baltimore; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

Baltimore; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Baltimore; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Baltimore; Weinberg Cancer Institute at Franklin Square Hospital
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Baltimore; Cancer Center at Greater Baltimore Medical Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Baltimore; Greater Baltimore Medical Center, Cancer Center
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Baltimore; Harbor View Cancer Center
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Baltimore; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Baltimore; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Bethesda; Center for Cancer and Blood Disorders
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Bethesda; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bethesda; Oncology Care Associates
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Bethesda; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Chevy Chase; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Cumberland; Western Maryland Health System Braddock Campus
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Frederick; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Rockville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Rockville; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Rockville; Research Site:
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer

Salisbury; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Silver Spring; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Center
HER2-positive Breast Cancer Study CRAD001J2101

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Washington; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Wheaton; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Massachusetts

Boston; Brigham and Women's Hospital
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy

Boston; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Boston; Boston Medical Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Boston; Dana-Farber Cancer Inst
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer

Boston; Dana-Farber Cancer Inst
A Study of Dasatinib (BMS-354825) in Patients With Advanced ‘Triple-Negative’ Breast Cancer

Burlington; Lahey Clinic
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy

Fall River; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Peabody; North Shore Medical Center, Cancer Center
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Pittsfield; Berkshire Hematology Oncology
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Pittsfield; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Plymouth; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Springfield; Baystate Medical Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Michigan

Adrian; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Ann Arbor; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Battle Creek; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Bay City; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Big Rapids; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Detroit; Research Site:
A Study of Epothilone D in Patients With Metastatic Breast Cancer

Detroit; Research Site:
A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer

East Lansing; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Flint; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Free Soil; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Grand Rapids; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Grand Rapids; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Grosse Pointe Woods; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Jackson; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Kalamazoo; Kalamazoo Hematology and Oncology
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Kalamazoo; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lambertsville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Lansing; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Lapeer; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Livonia; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Marquette; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Mt Clemens; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Muskegon; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Royal Oaks; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Saginaw; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Saint Joseph; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Southfield; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Southfield; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer

Traverse City; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Site
A clinical study of an investigational drug designed to help slow the progression of HER2-positive metastatic breast cancer

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Woodhaven; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Wyoming; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Minnesota

Burnsville; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Coon Rapids; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Edina; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Edina; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Edina; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Fridley; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Maplewood; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Minneapolis; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Minneapolis; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Minneapolis; The University of Minnesota Cancer Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies

Robbinsdale; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Saint Louis Park; Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

St Louis Park; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

St. Paul; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Woodbury; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Mississippi

South Haven; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Missouri

Columbia ; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Columbia; Ellis Fischel Cancer Center
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Jeferson City; Columbia Comprehensive Cancer Care Clinic & Research Institute
First or Second Line Metastatic Breast Cancer with previous Avastin therapy

Jefferson City; Columbia Comprehensive Cancer Care Clinic & Research Institute
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Jefferson City; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Kansas City; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

Kansas City; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Kansas City; Kansas City Cancer Center
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer

Kansas City; Research Site:
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Springfield; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

St Louis; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

St Louis; Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.

St Louis; Research Site:
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

St. Louis; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

St. Louis; St. John's Mercy Medical Center, David C. Pratt Cancer Center
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer

Various Cities; Research Center
HER2-positive Breast Cancer Study CRAD001J2101

Various Cities; Research Center
Breast Cancer Study CZOL446E2352

Montana

Billings; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Billings; Hematology Oncology Centers of the Northern Rockies
Paclitaxel with or without Sorafenib in Treating Patients with Locally Recurrent or Metastatic Breast Cancer

Great Falls; Research Site:
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.

Great Falls; Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.

Great Falls; Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients W